Overview
Mohammad Zahid is a Hematologist Oncology specialist and a Hematologist in Dallas, Texas. Dr. Zahid is rated as an Experienced provider by MediFind in the treatment of Light Chain Deposition Disease (LCDD). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Acute Promyelocytic Leukemia, Leukemia, Bone Marrow Transplant, and Splenectomy.
His clinical research consists of co-authoring 44 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Light Chain Deposition Disease (LCDD).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5151 Maple Ave, Dallas, TX 75235
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Texas Oncology, P.A.
Houston Holmes is a Hematologist and an Oncologist in Dallas, Texas. Dr. Holmes has been practicing medicine for over 35 years and is rated as an Advanced provider by MediFind in the treatment of Light Chain Deposition Disease (LCDD). His top areas of expertise are Myelodysplastic Syndrome (MDS), Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration.
University Of Texas Southwestern Medical Center At Dallas
Ina Patel is a Hematologist Oncology specialist and a Hematologist in Dallas, Texas. Dr. Patel is rated as an Advanced provider by MediFind in the treatment of Light Chain Deposition Disease (LCDD). Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma.
University Of Texas Southwestern Medical Center At Dallas
Sandra Hofmann is a Hematologist Oncology specialist and a Hematologist in Dallas, Texas. Dr. Hofmann is rated as an Advanced provider by MediFind in the treatment of Light Chain Deposition Disease (LCDD). Her top areas of expertise are Hemolytic-Uremic Syndrome, D-Plus Hemolytic Uremic Syndrome, Atypical Hemolytic Uremic Syndrome (aHUS), Bone Marrow Aspiration, and Splenectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Promyelocytic LeukemiaDr. Zahid isAdvanced. Learn about Acute Promyelocytic Leukemia.
- Experienced
- Achilles Tendon RuptureDr. Zahid isExperienced. Learn about Achilles Tendon Rupture.
- Acute Monoblastic Leukemia (AmoL)Dr. Zahid isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Zahid isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Zahid isExperienced. Learn about Agranulocytosis.